Numinus Wellness (NUMI.V) announced that Health Canada has cleared their MAPS-sponsored single-arm, open-label safety and feasibility study evaluating MDMA-assisted therapy for post-traumatic stress disorder (PTSD). The study is being…
Health Canada
Medexus Pharmaceuticals (MDP.T) received Health Canada’s Notice of Compliance to commercialize treosulfan today, according to a press release. Treosulfan will be sold in Canada using the brand name…
Mydecine Innovations Group (MYCO.C) announced that they have received approval from Health Canada to significantly expand their cultivation capacity at their Canadian Current Good Manufacturing Practice (cGMP) facility at…
Empower Clinics (CBDT.C) Health Canada and FDA authorized at-home saliva COVID-19 RT-PCR (or reverse transcription polymerase chain reaction) test went live on the Air Canada website for purchase today,…
Numinus Wellness (NUMI.V) and Optimi Health (OPTI.C) announced they have submitted a pre-clinical trial application to Health Canada. The application was submitted through Impact Clinical Trials Accelerator at the…
Valeo Pharma (VPH.C) announced they have entered into a Product Listing Agreement (PLA) with the Executive Officer of the Ontario Public Drug Program for the listing of Redesca and…
Delic Holdings (DELC.C) announced that their acquisition target, Complex Biotech Discovery Ventures (CBDV), has hired Dr. Eric Janusson as their Lead Chemist. Dr. Eric Janusson is an analytical organometallic…
Vivo Cannabis’ (VIVO.T) Vanluven facility in Napanee, Ontario, landed its European Union good manufacturing practices (EU-GMP) certification today, according to a press release. The certification gives Vivo the nod…
Pure Extracts Technologies (PULL.C) inked a letter of intent with ShroomBoom Labs/Floja Bioscience to supply psychedelic mushroom biomass today, according to a press release. The terms of the LOI…
Mydecine Innovations Group (MYCO.C) expanded their relationship with Applied Pharmaceutical Innovation (API) to include the University of Alberta in support of multiple drug development and clinical trials, according to…